Investing.com - Health care conglomerate Johnson & Johnson reported better-than-expected third quarter earnings on the back of strong revenue figures, it announced early Tuesday.
Earlier in the day, in its third quarter earnings report, J&J said earnings per share came in at USD1.36, beating expectations for earnings of USD1.32 per share.
The company’s third quarter revenue totaled USD17.58 billion, above expectations for revenue of USD17.45 billion.
The strong earnings prompted the firm to raise its full-year earnings outlook. J&J now sees full year earnings per share to come in at a range between USD5.44 and USD5.49, compared to a previous estimate in the range of USD5.40 and USD5.47 per share.
Immediately after the earnings announcement, Johnson & Johnson shares rose 1.6% in trading prior to the opening bell.
Meanwhile, the outlook for U.S. equity markets was mixed. The Dow Jones Industrial Average futures pointed to a gain of 0.1% at the open, S&P 500 futures indicated a decline of 0.1%, while the Nasdaq 100 futures indicated a gain of 0.1% at the open.